OTHER ASSETS - Narrative (Details) - USD ($) |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
|
| Schedule of Equity Method Investments [Line Items] | |||
| Equity investments, net of cumulative impairment | $ 33,000,000 | $ 29,000,000 | |
| Impairment recorded | 0 | $ 0 | |
| Fair Value Measured at Net Asset Value Per Share | |||
| Schedule of Equity Method Investments [Line Items] | |||
| Investments measured at NAV | 142,000,000 | 150,000,000 | |
| Sinclair Broadcast Group, LLC | |||
| Schedule of Equity Method Investments [Line Items] | |||
| Equity investments, net of cumulative impairment | 20,000,000 | 17,000,000 | |
| Impairment recorded | 0 | $ 0 | |
| Sinclair Broadcast Group, LLC | Fair Value Measured at Net Asset Value Per Share | |||
| Schedule of Equity Method Investments [Line Items] | |||
| Investments measured at NAV | $ 14,000,000 | $ 13,000,000 | |
| X | ||||||||||
- Definition Fair value of investment other than investment in equity security, investment in debt security and equity method investment. Includes, but is not limited to, investment in certain entities that calculate net asset value per share. Example includes, but is not limited to, investment in hedge fund, venture capital fund, private equity fund, and real estate partnership or fund. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss on investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|